**INTRODUCTION:** Radiation of the breast with a saline tissue expander in situ has been managed successfully for many years despite the presence of an embedded metallic injection port. A new breast tissue expander has been introduced that is filled with carbon dioxide released via remote control from a stainless-steel reservoir located within the expander. Radiation oncologists and medical physicists will need to consider what effect the gas filled chamber and metal components within the expander have on their treatment planning and dosimetry. Breast air expanders require a wedged pair planning technique however, Saline expanders can be planned with a IMRT hybrid technique. It is critical to understand the contour and overrides to get an accurate dose distribution in pinnacle.

**METHODS:** All patients referred for radiation therapy with the AeroForm Tissue Expander in place were evaluated at the Genesis Cancer Care in Western Australia. Treatment planning was conducted after evaluation of the device properties. The Radiation Oncologist marks the clinical target volume (skin, subcutaneous tissue), a planning target volume is then created (beam generated ptv).

**RESULTS:** Patients referred to the radiation oncology team with the AeroForm Tissue Expander in place underwent routine CT guided treatment planning. Treatment plans were implemented with consideration of the density and position of the stainless-steel reservoir as well as the potential effects of radiation through an air-filled chamber. Details of the planning technique are included. A total of 9 patients with Aeroform Tissue Expanders in situ have been treated with chest wall Radiation Therapy for local control. All patients were able to complete their course of radiation without noticeable effect of the AeroForm Tissue Expander on acute toxicity.

**CONCLUSIONS:** CT based optimization of dosimetry with respect to the properties of the new gas-based expander was completed to successfully reduce dose variation in patients with the gas-filled expander in place. When patients are referred for breast radiation therapy, it is important to inform the radiation oncologist of the presence of this expander for optimal treatment planning.
